At a glance
- Originator ALTANA Pharma
- Class Antihyperglycaemics
- Mechanism of Action Carnitine O-palmitoyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Diabetes mellitus